BackAbattis Bioceuticals Overview

Abattis Bioceuticals Receivables

Latest receivables for ATTBF: $160K.

Get informed when a big investor buys or sells

+ Follow
Receivables
$155079.00
↓ 72.70% YoYΔ $-412941.00 vs prior year quarter

Peer trimmed avg / median

Loading

Abattis Bioceuticals Receivables History

Loading

Abattis Bioceuticals vs. peers: Receivables Comparison

Loading

Abattis Bioceuticals Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Abattis Bioceuticals (ATTBF) FAQ

As of the most recent data (September 2019), ATTBF shows a receivables of $160K. That compares with $570K in the prior-year period — down 72.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ATTBF's receivables is now $160K (was $570K) — a 72.7% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Abattis Bioceuticals is outperforming or lagging.

Tracking ATTBF's receivables over time shows whether Abattis Bioceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $160K That compares with $570K in the prior-year period — down 72.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Abattis Bioceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $160K) with ownership activity and broader fundamentals.

Abattis Bioceuticals's receivables is $160K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.